Multi-ingredient, caffeine-containing dietary supplements: History, safety, and efficacy

Clinical Therapeutics

Volumn 37, Issue 2, 2015, Pages 275-301

  Gurley, Bill J ^a   Steelman, Susan C ^b   Thomas, Sheila L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

caffeine; dietary supplements; energy drinks; Ephedra; Ephedra free

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; EPHEDRINE; PHENYLPROPANOLAMINE; SOUR ORANGE EXTRACT; ALKALOID; CENTRAL STIMULANT AGENT; DRUG COMBINATION;

AREA UNDER THE CURVE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; DRUG TRANSFORMATION; ELIMINATION HALF-LIFE; ENERGY DRINK; EPHEDRA; HEART ARRHYTHMIA; HEART INFARCTION; HEAT INJURY; HISTORY OF MEDICINE; HUMAN; HYPERGLYCEMIA; HYPERTENSIVE CRISIS; HYPOKALEMIA; META ANALYSIS (TOPIC); NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; SEIZURE; SYSTEMATIC REVIEW; VOLUME OF DISTRIBUTION; ADVERSE EFFECTS; CANADA; CHEMISTRY; DEVICE RECALL; DRUG COMBINATION; HISTORY; UNITED STATES;

ALKALOIDS; CAFFEINE; CANADA; CENTRAL NERVOUS SYSTEM STIMULANTS; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; ENERGY DRINKS; EPHEDRA; EPHEDRINE; HISTORY, 20TH CENTURY; HUMANS; SAFETY-BASED MEDICAL DEVICE WITHDRAWALS; UNITED STATES;

EID: 84923675614     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.08.012     Document Type: Review

References (277)

1. B.B. Fredholm Notes on the history of caffeine use Handb Exp Pharmacol 200 2011 1 9
2. C.D. Frary, R.K. Johnson, and M.Q. Wang Food sources and intakes of caffeine in the diets of persons in the United States J Am Diet Assoc 105 2005 110 113
3. J.A. Ribeiro, and A.M. Sebastião Caffeine and adenosine J Alzheim Dis 20 2010 S3 S15
4. N.P. Riksen, P. Smits, and G.A. Rongen The cardiovascular effects of methylxanthines Handb Exp Pharmacol 200 2011 413 437
5. J.E. James Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously Psychosom Med 66 2004 63 71
6. R.J. Hoffman Methylxanthines and selective β2 agonists L.S. Nelson, N.A. Lewin, M.A. Howland, R.S. Hoffman, L.R. Goldfrank, N.E. Flomenbaum, Goldfrank's Toxicologic Emergencies 9th ed 2011 McGraw-Hill New York
7. J. Cole One the deleterious effects produced by drinking tea and coffee in excessive quantities Lancet 2 1833 274 278
8. Dietary Supplement Health and Education Act (DSHEA), Public Law 103-417, 1994; Act 42 U.S.C. 287C-11.
9. C.R. Lake, and R.S. Quirk CNS stimulants and the look-alike drugs Psychiatr Clin N Am 7 1984 689 701
10. A.H. Hayes New drug status of OTC combination drug products containing caffeine, phenylpropanolamine, and ephedrine Fed Reg 47 1982 35344 35346
11. Cold, cough, allergy, bronchodilator, and anti-asthmatic drug products for over-the-counter human use; tentative final monograph for combination drug products Fed Reg 53 1988 30522 30564
12. J. Hallas, L. Bjerrum, H. Støvring, and M. Andersen Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study Am J Epidemiol 168 2008 966 973
13. Anonymous Adverse events associated with ephedrine-containing products - Texas, December 1993-September 1995 JAMA 276 1996 1711 1712
14. S. Pace Ma huang food supplement toxicity in two adolescents J Toxicol Clin Toxicol 34 1996 598
15. S.M. Zaacks, L. Klein, and C.D. Tan Hypersensitivity myocarditis associated with ephedra use Clin Toxicol 37 1999 485 489
16. K.A. Zahn, R.L. Li, and R.A. Purssell Cardiovascular toxicity after ingestion of "herbal ecstacy." J Emerg Med 17 1999 289 291
17. C.A. Haller, and N.L. Benowitz Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids N Engl J Med 343 2000 1833 1838
18. K.M. Jacobs, and K.A. Hirsch Psychiatric complications of ma-huang Psychosomatics 41 2000 58 62
19. K. Vahedi, V. Domigo, P. Amarenco, and M.-G. Bousser Ischemic stroke in a sportsman who consumed ma huang extract and creatine monohydrate for body building J Neurol Neurosurg Psychiatry 68 2000 112 113
20. J. Kaberi-Otarod, R. Conetta, A. Farkash, and K. Kundo Ischemic stroke in a user of Thermadrene: a case study in alternative medicine Clin Pharmacol Ther 71 2002 P92
21. J.T. Favreau, M.L. Ryu, and G. Braunstein Severe hepatoxicity associated with the supplement LipoKinetix Ann Int Med 136 2002 590 595
22. S.J. Traub, W. Hoyek, and R.S. Hoffman Dietary supplements containing ephedra alkaloids (Report of myocardial infarction after using ephedra) N Engl J Med 344 2001 1096
23. D.R. Kockler, M.W. McCarthy, and C.L. Lawson Seizure activity and unresponsiveness after Hydroxycut ingestion Pharmacotherapy 21 2001 647 651
24. F. du Boisgueheneuc, A. Lannuzel, D. Caparros-Lefebvre, and T. De Broucker Cerebral infarction in a patient consuming Ma Huang extract and guarana Presse Medicale 30 2001 166 167
25. D. Samenuk, M.S. Link, and M.K. Homoud Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine Mayo Clin Proc 77 2002 12 16
26. G.E. Wettach, and S.G. Falvey A mysterious blood pressure increase in a drilling naval reservist Mil Med 167 2002 521 523
27. D. Roberts, S. Setzer, and S. Bangh The most unkindest cut of all: pontine hemorrhage associated with ephedrine J. Toxicol Clin Toxicol 40 2002 616
28. S.H. Rezkalla, J. Mesa, P. Sharma, and R.A. Kloner Myocardial infarction temporally related to ephedra - a possible role for the coronary microcirculation Wisc Med J 101 2002 64 66
29. M.L. Verduin, and L.A. Labbate Psychosis and delirium following Metabolife use Psychopharmacol Bull 36 2002 42 45
30. J. Kaberi-Otarod, R. Conetta, K.K. Kundo, and A. Farkash Ischemic stroke in a user of Thermadrene: a case study in alternative medicine Clin Pharmacol Ther 72 2002 343 346
31. J. Schweinfurth, and E. Pribitkin Sudden hearing loss associated with ephedra use Am J Health Syst Pharm 60 2003 375 377
32. J.M. Boerth, and C.F. Caley Possible case of mania associated with ma-huang Pharmacotherapy 23 2003 380 383
33. L.B. Morgenstern, C.M. Viscoli, and W.N. Kernan Use of Ephedra-containing products and risk for hemorrhagic stroke Neurology 60 2003 132 135
34. J.D. Estes, D. Stolpman, and A. Olyaei High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure Arch Surg 138 2003 852 858
35. S.C. Miller, and C. Waite Ephedrine-type alkaloid-containing dietary supplements and substance dependence Psychomatics 44 2003 508 511
36. C.N. Krome, and A.M. Tucker Cardiac arrhythmia in a professional football player: was ephedra to blame? Phys Sportsmed 31 2003 1 8
37. R. Walton, and G.H. Manos Psychosis related to ephedra-containing herbal supplement use South Med J 96 2003 718 720
38. S.C. Miller Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements Mil Med 169 2004 87 93
39. R.J. Foxford, D.J. Sahlas, and K.A. Wingfield Vasospasm-induced stroke in a varsity athlete secondary to ephedrine ingestion Clin J Sport Med 13 2003 183 185
40. S.D. Naik, and R.S. Freudenberger Ephedra-associated cardiomyopathy Ann. Pharmacother 38 2003 400 403
41. J.M. Enders, P.P. Dobesh, and J.N. Ellison Acute myocardial infarction induced by ephedrine alkaloids Pharmacotherapy 23 2003 1645 1651
42. Final rule declaring dietary supplements containing ephedrine alkaloids Adulterated because they present an unreasonable risk Fed Reg 69 2004 6787 6854
43. J. Kole, and A. Barnhill Caffeine content labeling: a missed opportunity for promoting personal and public health J Caffeine Res 3 2013 108 113
44. D.L. Nykamp, M.N. Fackih, and A.L. Compton Possible association of acute lateral-wall myocardial infarction and bitter orange supplement Ann Pharmacother 38 2004 812 816
45. J.M. Nasir, S.J. Durning, and M. Ferguson Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine Mayo Clin Proc 79 2004 1059 1062
46. N.C. Bouchard, M.A. Howland, and H.A. Greller Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine Mayo Clin Proc 80 2005 541 545
47. C.A. Gange, C. Madais, and E.M. Felix-Getzik Variant angina associated with bitter orange in a dietary supplement Mayo Clin Proc 81 2006 545 548
48. J. Burke, G. Seda, D. Allen, and T.S. Knee A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement Mil Med 172 2007 656 658
49. R.O. Holmes, and J. Tavee Vasospasm and stroke attributable to ephedra-free Xenadrine: case report Mil Med 173 2008 708 710
50. G.J. Muller, and J.P. Smedema Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine S Afr Med J 98.5 2008 372
51. J.E. Thomas, J.A. Munir, P.Z. McIntyre, and M.A. Ferguson STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement Tex Heart J 36 2009 586 590
52. I. Ahmed Malignant hypertension and acute aortic dissection associated with caffeine-based ephedra-free dietary supplements: a case report Cases J 2 2009 6612
53. A. Karth, N. Holoshitz, and C.J. Kavinsky A case report of atrial fibrillation potentially induced by Hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines J Pharm Pract 23 2010 245 249
54. J. Moaddeb, T.S. Tofade, and M.B. Bevins Hypertensive urgency associated with Xenadrine EFX use J Pharm Pract 24 2011 400 403
55. C. Retamero, T. Rivera, and K. Murphy "Ephedra-free" diet pill-induced psychosis Psychosomatics 52 2011 579 582
56. G.L. Cvetanovich, P. Ramakrishnan, and J.P. Klein Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report J Med Case Rep 5 2011 548
57. C. Young, O. Oladipo, and S. Frasier Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d Mil Med 177 2012 1450 1454
58. M. Pendleton, S. Brown, C.M. Thomas, and B. Odle Potential toxicity of caffeine when used as a dietary supplement for weight loss J Dietary Suppl 10 2013 1 5
59. M.A. Heckman, K. Sherry, and E.G. de Mejia Energy dinks: an assessment of their market size, consumer demographics, ingredient profile, functionality, and regulations in the United States Comp Rev Food Sci Food Saf 9 2010 303 317
60. B.B. Worrall, D. Phillips, and K.K. Henderson Herbal energy drinks, phenylpropanoid compounds, and cerebral vasculopathy Neurology 65 2005 1137 1138
61. S.M. Seifert, J.L. Schaechter, E.R. Hershorin, and S.E. Lipshultz Health effects of energy drinks on children, adolescent, and young adults Pediatrics 127 2011 511 528
62. Trabulo D, Marques S, Pedroso E. Caffeinated energy drink intoxication. BMJ Case Rep. http://dx.doi.org/10.1136/bcr.09.2010.3322.
63. Gray B, Jipin DK, Semsarian C. Consumption of energy drinks: a new provocation test for primary arrhythmogenic diseases. Int J Cardiol. http://dx.doi.org/10.1016/j.ijcard.2012.05.121.
64. B.J. Wolk, M. Ganetsky, and K.M. Babu Toxicity of energy drinks Curr Opin Pediatr 24 2012 243 251
65. S.P. Nordt, G.M. Vilke, and R.F. Calrk Energy drink use and adverse effects among emergency department patients J Community Health 37 2012 976 981
66. A.M. Benjo, A.M. Pineda, and F.O. Nascimento Left main coronary artery acute thrombosis related to energy drink intake Circulation 125 2012 1447 1448
67. A. Kaoukis, V. Panagopoulou, H.R. Mojibian, and D. Jacoby Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink Circulation 125 2012 1584 1585
68. D. Rottlaender, L.J. Motloch, and S. Reda Cardiac arrest due to long QT syndrome associated with excessive consumption of energy drinks Int J Cardiol 158 2012 e51 e52
69. A. Usman, and A. Jawaid Hypertension in a young boy: an energy drink effect BMC Res Notes 5 2012 591
70. S. Dikici, A. Saritas, and F.H. Besir Do energy drinks cause epileptic seizure and ischemic stroke Am J Emerg Med 31 2013 274 e1-274.e4
71. J.L. Pomeranz, C.R. Munsell, and J.L. Harris Energy drinks: an emerging public health hazard for youth J Pub Health Policy 34 2013 254 271
72. B.V. Cotter, D.A.E. Jackson, and R.C. Merchant Energy drink and other substance use among adolescent and young adult emergency department patients Pediatr Emer Care 29 2013 1091 1097
73. S.M. Seifert, S.A. Seifert, and J.L. Schaechter An analysis of energy-drink toxicity in the National Poison Data System Clin Toxicol 51 2013 566 574
74. K.A. Sepkowitz Energy drinks and caffeine-related adverse effects JAMA 309 2013 243 244
75. M. Goldfarb, C. Tellier, and G. Thanassoulis Review of published cases of adverse cardiovascular events after ingestion of energy drinks Am J Cardiol 113 2014 168 172
76. A.M. Arria, and M.C. O'Brien The "high" risk of energy drinks JAMA 2011 (published online January 25, 2011)
77. A.S. Attwood Alcohol and caffeine: caffeinated alcohol beverages: a public health concern Alcohol Alcoholism 47 2012 370 371
78. M.C. O'Brien, T.P. McCoy, and S.D. Rhodes Caffeinated cocktails: energy drink consumption, high risk drinking, and alcohol-related consequences among college students Acad Emerg Med 15 2008 453 460
79. J. Howland, and D.J. Rohsenow Risks of energy drinks mixed with alcohol JAMA 309 2013 245 246
80. N.L. Benowitz Clinical pharmacology of caffeine Annu Rev Med 41 1990 277 288
81. J. Shi, N.L. Benowitz, C.P. Denaro, and L.B. Sheiner Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects Clin Pharmacol Ther 48 1990 277 285
82. A. Nehlig, J.L. Daval, and G. Debry Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects Brain Res Brain Res Rev 17 1992 139 170
83. A. Yang, A.A. Palmer, and H. de Wit Genetics of caffeine consumption and responses to caffeine Psychopharmacol 211 2010 245 257
84. J.V. Rétey, M. Adam, and R. Khatami A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep Clin Pharmacol Ther 81 2007 692 698
85. E.M. Byrne, J. Johnson, and A.F. McRae A genome-wide study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor Sleep 35 2012 967 975
86. K. Alsene, J. Deckert, P. Sand, and H. de Wit Association between A2a receptor gene polymorphisms and caffeine-induced anxiety Neuropsychopharmacology 28 2003 1694 1702
87. E. Childs, C. Hohoff, and J. Deckert Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety Neuropsychopharmacol 33 2008 2791 2800
88. M.C. Cornelis, A. El-Sohemy, and H. Campos Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption Am J Clin Nutr 86 2007 240 244
89. G. Renda, M. Zimarino, and I. Antonucci Genetic determinants of blood pressure responses to caffeine drinking Am J Clin Nutr 95 2012 241 248
90. D. Jiang, P.P. Jones, and D.R. Davis Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholamine polymorphic ventricular tachycardia Channels 4 2010 302 310
91. J.M. Brathwaite, L.A. Da Costa, and A. El-Sohemy Catechol-O-methyltransferase genotype is associated with self-reported increased heart rate following caffeine consumption J Caffeine Res 1 2011 123 130
92. R.J. Miller, K.G. Jackson, and T. Dadd The impact of the catechol-O-methyltransferase genotype on vascular function and blood pressure after acute green tea ingestion Mol Nutr Food Res 56 2012 966 975
93. P. Happonen, S. Voutilainen, T.-P. Tuomainen, and J.T. Salonen Catechol-O-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events PLoS One 1 2006 e117 10.1371/journal.pone.0000117
94. J. Blanchard, and S.J. Sawers The absolute bioavailability of caffeine in man Eur J Clin Pharmacol 24 1983 93 98
95. M.J. Arnaud Pharmacokinetics and metabolism of natural methylxanthines in animal and man Handb Exp Pharmacol 200 2011 33 91
96. C.P. Denaro, C.R. Brown, and M. Wilson Dose-dependency of caffeine metabolism with repeated dosing Clin Pharmacol Ther 48 1990 277 285
97. C.F. Thorn, E. Aklillu, and E.M. McDonagh PharmGKB summary: caffeine pathway Pharmacogenet Genomics 22 2012 389 395
98. N.L. Benowitz, P. Jacob, H. Mayan, and C. Denaro Sympathomimetic effects of paraxanthine and caffeine in humans Clin Pharmacol Ther 58 1995 684 691
99. J.A. Carrillo, and J. Benitez Clinically significant pharmacokinetic interactions between dietary caffeine and medications Clin Pharmacokinet 39 2000 127 153
100. A. Gunes, and M.-L. Dahl Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms Pharmacogenomics 9 2008 625 637
101. A.r. Josse, L.A. Da Costa, H. Campos, and A. El-Sohemy Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption Am J Clin Nutr 96 2012 665 671
102. P. Palatini, G. Ceolotto, and F. Ragazzo CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension J Hypertens 27 2009 1594 1601
103. M.C. Cornelis, A. El-Sohemy, E.K. Kabagambe, and Campos H. Coffee CYP1A2 genotype, and the risk of myocardial infarction JAMA 295 2006 1135 1141
104. X. Wang, W.Y. Lee, P.M. Or, and J.H. Yeung Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates Phytomedicine 16 2009 712 725
105. Y. Chen, P. Xiao, and D.S. Ou-Yang Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers Clin Exp Pharmacol Physiol 36 2009 828 833
106. Y. Chen, C.Q. Xiao, and Y.J. He Genistein alters caffeine exposure in healthy female volunteers Eur J Clin Pharmacol 67 2011 347 353
107. Y. Chen, W.H. Liu, and B.L. Chen Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers Ann Pharmacother 44 2010 1038 1045
108. W.X. Peng, H.D. Li, and H.H. Zhou Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers Eur J Clin Pharmacol 59 2003 237 241
109. U. Fuhr, K. Klittich, and A.H. Staib Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man Br J Clin Pharmacol 35 1993 431 436
110. C.R. Lake, G. Zaloga, D. Rosenberg, and B. Chernow Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study Am J Med 86 1989 427 432
111. N.J. Brown, D. Ryder, and R.A. Branch A pharmacodynamic interaction between caffeine and phenylpropanolamine Clin Pharmacol Ther 50 1990 363 371
112. C.A. Haller, P. Jacob, and N.L. Benowitz Enhanced stimulant and metabolic effects of combined ephedrine and caffeine Clin Pharmacol Ther 75 2004 259 273
113. M. Waluga, M. Janusz, and E. Karpel Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical impedance in obese women Clin Physiol 18 1998 69 76
114. R.W. Derlet, J.C. Tseng, and T.E. Albertson Potentiation of cocaine and d-amphetamine toxicity with caffeine Am J Emerg Med 10 1992 211 216
115. N. Vanattou-Saïfoudine, R. McNamara, and A. Harkin Caffeine provokes adverse interactions with 3,4-methylenedioxy-methamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators Br J Pharmacol 167 2012 946 959
116. L. Frau, N. Simola, and M. Morelli Contribution of caffeine to the psychostimulant, neuroinflammatory and neurotoxic effects of amphetamine-related drugs J Caffeine Res 3 2013 79 84
117. C. Chen, J. Biller, S.J. Willing, and A.M. Lopez Ischemic stroke after using the over the counter products containing ephedra J Neurol Sci 217 2004 55 60
118. F.J. Moawad, J.D. Hartzell, T.J. Biega, and C.J. Lettieri Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose South Med J 99 2006 511 514
119. R.C. Oh, and J.S. Henning Exertional heatstroke in an infantry officer taking ephedra-containing dietary supplements Mil Med 168 2003 429 430
120. C.E. Stahl, C.V. Borlongan, H. Szerlip, and M. Szerlip No pain, no gain - exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra Med Sci Monit 12 2006 CS81 CS84
121. Rhidian R. Running a risk? Sport supplement toxicity with ephedrine in an amateur marathon runner, with subsequent rhabdomyolysis. BMJ Case Reports. http://dx.doi.org/10.1136/bcr.11.2011.5093.
122. C. McLean, and T.E. Graham Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women J Appl Physiol 93 2002 1471 1478
123. C.A. Haller, M. Duan, P. Jacob, and N. Benowitz Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions Br J Clin Pharmacol 65 2008 833 840
124. K. Collomp, F. Anselme, and M. Audran Effects of moderate exercise on the pharmacokinetics of caffeine Eur J Clin Pharmacol 40 1991 279 282
125. G.H. Kamimori, S.M. Somani, R.G. Knowlton, and R.M. Perkins The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers Eur J Clin Pharmacol 31 1987 595 600
126. Y. Caraco, E. Zylber-Katz, E.M. Berry, and M. Levy Caffeine pharmacokinetics in obesity and following significant weight reduction Int J Obes Relat Metab Disord 19 1995 234 239
127. Skinner TL, Jenkins DG, Leveritt MD, et al. Factors influencing serum caffeine concentrations following caffeine ingestion. J Sci Med Sport. http://dx.doi.org/10.1016/j.jsams.2013.07.006.
128. J.W. Daniels, P.A. Molé, J.D. Shaffrath, and C.L. Stebbins Effects of caffeine on blood pressure, heart rate, and forearm blood flow during dynamic leg exercise J Appl Physiol 85 1998 154 159
129. C.L. Stebbins, J.W. Daniels, and W. Lewis Effects of caffeine and high ambient temperature on haemodynamic and body temperature responses to dynamic exercise Clin Physiol 21 2001 528 533
130. T.A. Astorino, R.L. Rohmann, K. Firth, and S. Kelly Caffeine-induced changes in cardiovascular function during resistance training Int J Sport Nutr Exerc Metab 17 2007 468 477
131. K. Woolf, W.K. Bidwell, and A.G. Carlson The effect of caffeine as an ergogenic aid in anaerobic exercise Int J Sport Nutr Exerc Metab 18 2008 412 429
132. P.J. Arciero, and M.J. Ormsbee Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women Appl Physiol Nutr Metab 34 2009 754 762
133. B.H. Sung, W.R. Lovallo, T. Whitsett, and M.F. Wilson Caffeine elevates blood pressure response to exercise in mild hypertensive men Am J Hypertens 8 1995 1184 1188
134. J.P. Higgins, and K.M. Babu Caffeine reduces myocardial blood flow during exercise Am J Med 126 2013 730 e1-730.e8
135. C.J.D. Sinclair, and J.D. Geiger Caffeine use in sports: a pharmacological review J Sports Med Phys Fitness 40 2000 71 79
136. J.M. Tunnicliffe, K.A. Erdman, and R.A. Reimer Consumption of dietary caffeine and coffee in physically active populations: physiological interactions Appl Physiol Nutr Metab 33 2008 1301 1310
137. S. Bent, T. Tiedt, M. Odden, and M.G. Shlipak The relative safety of ephedra compared with other herbal products Ann Intern Med 138 2003 468 471
138. A.D. Woolf, W.A. Watson, S. Smolinske, and T. Litovitz The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002 Clin Toxicol 43 2005 347 355
139. C.E. Dennehy, C. Tsourounis, and A.J. Horn Dietary supplement-related adverse events reported to the California Poison Control System Am J Health-Syst Pharm 62 2005 1476 1482
140. C.A. Haller, K.H. Meier, and K.R. Olson Seizures reported in association with use of dietary supplements Clin Toxicol 43 2005 23 30
141. S.R. Mehendale, B.A. Bauer, and C.S. Yuan Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine Am J Chin Med 32 2004 1 10
142. T.C. Westfall, and D.P. Westfall Adrenergic agonists and antagonists L.L. Brunton, Goodman & Gilman's The Pharmacologic Basis of Therapeutics 12th ed 2011 McGraw-Hill New York
143. B.J. Gurley, S.F. Gardner, L.M. White, and P. Wang Ephedrine pharmacokinetics following the ingestion of Ephedra sinica (ma huang) products Ther Drug Monit 20 1998 439 445
144. C.A. Haller, P. Jacob, and N.L. Benowitz Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use Clin Pharmacol Ther 71 2002 421 432
145. E. Magalhães, M.D. Gomes, and G.B. Barra Evaluation of the influence of the codon 16 polymorphism of the beta-2 adrenergic receptor gene on the incidence of arterial hypotension and ephedrine use in pregnant patients submitted to subarachnoid anesthesia Rev Bras Anestesiol 60 2010 228 236
146. W.D. Heiss, and I. Podreka Assessment of pharmacological effects on cerebral blood flow Eur Neurol 17 Suppl 1 1978 135 143
147. A. Nyska, E. Murphy, and J.F. Foley Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine Toxicol Sci 83 2005 388 396
148. R. Howden, P.R. Hanlon, and J.G. Petranka Ephedrine plus caffeine causes age-dependent cardiovascular responses in Fischer 344 rats Am J Physiol Heart Circ Physiol 288 2005 H2219 H2224
149. J.K. Dunnick, G. Kissling, and D.K. Gerken Cardiotoxicity of ma huang/caffeine or ephedrine/caffeine in a rodent model system Toxicol Pathol 3 2007 657 664
150. C.E. Brown, S.E. Trauth, and R.S. Grippo Combined effects of ephedrine-containing dietary supplements, caffeine, and nicotine on morphology and ultrastructure of rat hearts J Caffeine Res 2 2012 123 132
151. M. Carlson, and R.D. Thompson Liquid chromatographic determination of methylxanthines and catechins in herbal preparations containing guarana J AOAC Int 81 1998 691 701
152. J.D. Lambert, S. Sang, and C.S. Yang Biotransformation of green tea polyphenols and the biological activities of those metabolites Mol Pharm 4 2007 819 825
153. M.N. Clifford, J.J. van der Hooft, and A. Crozier Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols Am J Clin Nutr 98 2013 1619S 1630S
154. H. Lu, X. Meng, and C.S. Yang Enzymology of methylation of tea catechins and inhibition of catechol-o-methyltransferase by (-)-epigallocatechin gallate Drug Metab Disp 31 2003 572 579
155. A.G. Dulloo, J. Seydoux, and L. Girardier Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity Int J Obesity 24 2000 252 258
156. S. Misaka, J. Yatabe, and F. Müller Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects Clin Pharmacol Ther 95 2014 432 438
157. Y. Kubota, K. Umegaki, and N. Tanaka Safety of dietary supplements: chronotropic and inotropic effects on rat atria Biol Pharm Bull 25 2002 197 200
158. A. Fugh-Berman, and A. Myers Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research Exp Biol Med 229 2004 698 704
159. S.J. Stohs, H.G. Preuss, and M. Shara A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine Int J Med Sci 9 2012 527 538
160. L.G. Rossato, V.M. Costa, and R.P. Limberger Synephrine: from trace concentrations to massive consumption in weight-loss Food Chem Toxicol 49 2011 8 16
161. Gurley BJ, Ali S. Toxicity of multi-component ephedra-containing dietary supplements. AAPS J. 2001 [abstract]. http://abstracts.aaps.org/SecureView/AAPSJournal/k998z12k0bcu2svbttqa.htm. Accessed April 20, 2014.
162. C.W. Lau, X.Q. Yao, and Z.Y. Chen Cardiovascular actions of berberine Cardiovasc Drug Rev 19 2001 234 244
163. Y.P. Cheng, Y.H. Wang, L.P. Cheng, and R.R. He Electrophysiological effects of capsaicin on pacemaker cells in sinoatrial nodes of rabbits Acta Pharmacol Sin 24 2003 826 830
164. Y.G. Wang, A.V. Zima, and X. Ji Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes Am J Physiol Heart Circ Physiol 295 2008 H851 H859
165. +-pumping ATPase in skeletal and cardiac sarcoplasmic reticulum Biochim Biophys Acta 903 1987 96 102
166. C. Chen-Scarabelli, S.E. Hughes, and G. Landon A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins Eur J Heart Fail 7 2005 927 930
167. Flanagan CM, Kaesberg JL, Mitchell ES, et al. Coronary artery aneurysm and thrombosis following chronic ephedra use. Int J Cardiol. http://dx.doi.org/10.1016/j.ijcard.2008.6.081.
168. J.B. Myers, K.M. Guskiewicz, and B.L. Riemann Syncope and atypical chest pain in an intercollegiate wrestler: a case report J Athlet Train 34 1999 263 266
169. S.L. Scoville, J.W. Gardner, and A.J. Magill Nontraumatic deaths during U.S. armed forces basic training, 1977-2001 Am J Prev Med 26 2004 205 212
170. F. Magkos, and S.A. Kavouras Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects Sports Med 34 2004 871 889
171. R. Sachdeva, S. Sivasankaran, and R.F. Fishman Coronary thrombosis related to use of Xenadrine RFA Tex Heart J 32 2005 74 77
172. R.Y. Forte, Precoma-Neto, and N.C. Neto Myocardial infarction associated with the use of a dietary supplement rich in ephedrine in a young athlete Arq Bras Cardiol 87 2006 e179 e181
173. K.J. Kleinjan The cardiovascular effects of caffeine and ephedrine during exercise [master's thesis] 2003 South Dakota State University Brookings, SD
174. B.J. Gurley, S.F. Gardner, and M.A. Hubbard Content versus label claims in ephedra-containing dietary supplements Am J Health-Syst Pharm 57 2000 963 969
175. S.F. Gardner, A.M. Franks, and B.J. Gurley Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers Am J Cardiol 91 2003 1510 1513
176. B.F. McBride, A.K. Karapanos, and A. Krudysz Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized trial JAMA 291 2004 216 221
177. C.A. Haller, P. Jacob, and N.L. Benowitz Short-term metabolic and hemodynamic effects of ephedra and guarana combinations Clin Pharmacol Ther 77 2005 560 571
178. P.G. Shekelle, M.L. Hardy, and S.C. Morton Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis JAMA 289 2003 1537 1545
179. V. Donadio, P. Bonsi, and I. Zele Myoglobinuria after ingestion of extracts of guarana, Ginkgo biloba and kava Neurol Sci 21 2000 124
180. I.A. Mansi, and J. Huang Rhabdomyolysis in response to weight-loss herbal medicine Am J Med Sci 327 2004 356 357
181. S. Dehoney, and M. Wellein Rhabdomyolysis associated with the nutritional supplement Hydroxycut Am J Health Syst Pharm 66 2009 142 148
182. R.K. Elsayed, J.K. Glisson, and D.S. Minor Rhabdomyolysis associated with the use of a mislabeled "acai berry" dietary supplement Am J Med Sci 342 2011 535 538
183. K.W. Andrews, A. Schweitzer, and C. Zhao The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients Anal Bioanal Chem 389 2007 231 239
184. L. Foster, M.C. Allan, and A. Khan Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects Clin Pharmacol Ther 93 2013 267 274
185. Z. Huang, S. Xiao, and D. Luo Simultaneous determination of sibutramine and N-di-desmethylsibutramine in dietary supplements for weight control by HPLC-ESI-MS J Chromatogr Sci 46 2008 707 711
186. Y. Zhang, R.M. Woods, Z.S. Breitbach, and D.W. Armstrong 1,3-dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? Drug Test Anal 4 2012 986 990
187. Cohen PA, Travis JC, Venhuis BJ. A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test Anal. http://dx.doi.org/10.1002/dta.1578.
188. M.J. Eliason, A. Eichner, and A. Cancio Case reports: Death of active duty soldiers following ingestion of dietary supplement containing 1,3-diethylamylamine (DMAA) Mil Med 177 2012 1455 1459
189. S.W. Tam, M. Worcel, and M. Wyllie Yohimbine: a clinical review Pharmacol Ther 91 2001 215 243
190. 2-adrenergic blockade with yohimbine: bimodal, epistatic influence of cytochrome P450-mediated drug metabolism Clin Pharmacol Ther 76 2004 139 153
191. J. Tank, K. Heusser, and A. Diedrich Yohimbine attenuates baroreflex-mediated bradycardia in humans Hypertension 50 2007 899 903
192. V.K. Yeragani, M. Tancer, and T. Uhde Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder Psychiatr Res 121 2003 185 196
193. T. Kearney, N. Tu, and C. Haller Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases Ann Pharmacother 44 2010 1022 1029
194. S. Bent, A. Padula, and J. Neuhaus Safety and efficacy of Citrus aurantium for weight loss Am J Cardiol 94 2004 1359 1361
195. J.Y. Jin, S.H. Park, and J.H. Bae Uncoupling by (-)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP Pharmacol Res 56 2007 237 247
196. J. Kang, H. Cheng, and J. Ji In vitro electrocardiographic and cardiac ion channel effects of (-)-epigallocatechin-3-gallate, the main catechin of green tea J Pharmacol Exp Ther 334 2010 619 626
197. K. Kelemen, C. Kiesecker, and E. Zitron Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels Biochem Biophys Res Comm 364 2007 429 435
198. R. Gugler, and H.J. Dengler Inhibition of human liver catechol-O-methyltransferase by flavonoids Naunyn Schmiedebergs Arch Pharmacol 276 1973 223 233
199. S.E. Dixon Clarke, and R.R. Ramsay Dietary inhibitors of monoamine oxidase A J Neural Transm 118 2011 1031 1041
200. S. Carradori, M. D'Ascenzio, and P. Chimenti Selective MAO-B inhibitors: a lesson from natural products Mol Divers 18 2014 219 243
201. E. Zitron, E. Scholz, and R.W. Owen QTc prolongation by grapefruit juice and is potential pharmacological basis: hERG channel blockade by flavonoids Circulation 111 2005 835 838
202. B.J. Gurley Pharmacokinetic herb-drug interactions (Part 1): origins, mechanisms, and the impact of botanical dietary supplements Planta Med 78 2012 1478 1489
203. B.J. Gurley, K.E. Fifer, and Z. Gardner Pharmacokinetic herb-drug interactions (Part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance Planta Med 78 2012 1490 1514
204. B.J. Gurley Emerging technologies for improving phytochemical bioavailability: benefits and risks Clin Pharmacol Ther 89 2011 915 919
205. R.H. Alasbahi, and M.F. Melzig Forskolin and derivatives as tools for studying the role of cAMP Pharmazie 67 2012 5 13
206. M.R. Bristow, R. Ginsburg, and A. Strosberg Pharmacology and inotropic potential of forskolin in the human heart J Clin Invest 74 1984 212 223
207. T. Nishikawa, S. Ishiyama, K. Takeda, and T. Kasajima The effect of forskolin on the teratogenicity of methylxanthines in the chick embryo heart Reprod Toxicol 9 1995 165 168
208. B. Min, B.F. McBride, and M.J. Kardas Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement Am J Health-Syst Pharm 62 2005 1582 1585
209. C. Sale, R.C. Harris, S. Delves, and J. Corbett Metabolic and physiologic effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males Int J Obes 30 2006 764 773
210. J.G. Seifert, A. Nelson, and J. Devonish Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans Int J Med Sci 8 2011 192 197
211. B. Min, B.F. McBride, and M.J. Kardas Electrocardiographic effects of an ephedra-free, multicomponent weight-loss supplement in healthy volunteers Pharmacother 25 2005 654 659
212. C.A. Haller, N.L. Benowitz, and P. Jacob Hemodynamic effects of ephedra-free weight-loss supplements in humans Am J Med 118 2005 998 1003
213. R.J. Bloomer, R.E. Canale, and M.M. Blankenship Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study Lipids Health Dis 8 2009 32 10.1186/1476-511X-8-32
214. N.P. Seeram, S.M. Henning, and Y. Niu Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity J Agric Food Chem 54 2006 1599 1603
215. C.O. Hoyte, D. Albert, and K.J. Heard The use of energy drinks, dietary supplements, and prescription medications by United States college students to enhance athletic performance J Community Health 38 2013 575 580
216. D. Taddeo, J. Harvey, and A. Boutin Health hazards related to energy drinks: are we looking for them? Paediatr Child Health 17 2012 101
217. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (January 10, 2013). The DAWN Report: Update on emergency department visits involving energy drinks: a continuing public health concern. Rockville, MD.
218. J.P. Higgins, T.D. Tuttle, and C.L. Higgins Energy beverages: content and safety Mayo Clin Proc 85 2010 1033 1041
219. T.M. McLellan, and H.R. Lieberman Do energy drinks contain active components other than caffeine? Nutr Rev 70 2012 730 744
220. A.M. Franks, J.M. Schmidt, K.R. McCain, and M. Fraer Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure Ann Pharmacother 46 2012 192 199
221. M.I. Worthley, A. Prabhu, and P. De Sciscio Detrimental effects of energy drink consumption on platelet and endothelial function Am J Med 123 2010 184 187
222. + sensitivity of chemically skinned rat heart J Physiol 422 1990 499 511
223. S.E. Ferreira, M.T. de Mello, S. Pompéia, and M.L.O. de Souza-Formigoni Effects of energy drink ingestion on alcohol intoxication Alcohol Clin Exp Res 30 2006 598 605
224. M.C. O'Brien, T.P. McCoy, and K.L. Egan Caffeinated alcohol, sensation seeking, and injury risk J Caffeine Res 3 2013 59 66
225. L. Berger, M. Fendrich, and D. Fuhrmann Alcohol mixed with energy drinks: are there associated consequences beyond hazardous drinking in college students? Addict Behav 38 2013 2428 2432
226. A.M. Kurtz, J. Leong, and M. Anand Effects of caffeinated versus decaffeinated energy shots on blood pressure and heart rate in healthy young volunteers Pharmacother 33 2013 779 786
227. 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans Int. J Obes 19 1995 678 685
228. S.S. Vansal, and D.R. Feller Direct effects of ephedrine isomers on human β-adrenergic receptor subtypes Biochem Pharmacol 58 1999 807 810
229. E.E. Blaak, M.A. Van Baak, K.P.G. Kempen, and W.H.M. Saris Role of α- and β-adrenoceptors in sympathetically mediated thermogenesis Am J Physiol 264 1993 E11 E17
230. 3-adrenoceptors-findings and challenges Naunyn-Schmied Arch Pharmacol 382 2010 103 108
231. A. Astrup Thermogenic drugs as a strategy for treatment of obesity Endocrine 13 2000 207 212
232. C.N. Boozer, J.A. Nasser, and S.B. Heymsfeld An herbal supplement containing ma huang-guarana for weight loss: a randomized, double-blind trial Int. J. Obes Relat Metab Disord 25 2001 316 324
233. C.N. Boozer, P.A. Daly, and P. Homel Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial Int J Obes Relat Metab Disord 26 2002 593 604
234. D.S. Kalman, C.M. Colker, Q. Shi, and M.A. Swain Effects of a weight-loss aid in healthy overweight adults: double-blind, placebo-controlled clinical trial Curr Ther Res 61 2000 199 205
235. C.S. Coffey, D. Steiner, B.A. Baker, and D.B. Allison A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment Int J Obes 28 2004 1411 1419
236. F.L. Greenway, L. de Jonge, and D. Blanchard Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition Obes Res 12 2004 1152 1157
237. R.M. Hackman, P.J. Havel, and H.J. Schwartz Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial Int J Obes 30 2006 1545 1556
238. A.G. Dulloo Herbal stimulation of ephedrine and caffeine in treatment of obesity Int J Obes 26 2002 590 592
239. D.G. Bell, I. Jacobs, and J. Zamecnik Effects of caffeine, ephedrine and their combination on time to exhaustion during high intensity exercise Eur J Appl Physiol 77 1998 427 433
240. D.G. Bell, and I. Jacobs Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test Aviat Space Environ Med 70 1999 325 329
241. D.G. Bell, I. Jacobs, McLellan, and J. Zamecnik Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect Aviat Space Environ Med 71 2000 415 419
242. D.G. Bell, I. Jacobs, and K. Ellerington Effect of caffeine and ephedrine ingestion on anaerobic exercise performance Med Sci Sports Exerc 33 2001 1399 1403
243. D.G. Bell, T.M. McLellan, and C.M. Sabiston Effect of caffeine and ephedrine on 10-km run performance Med Sci Sports Exerc 34 2002 344 349
244. I. Jacobs, H. Pasternak, and D.G. Bell Effects of ephedrine, caffeine, and their combination on muscular performance Med Sci Sports Exerc 35 2003 987 994
245. A.D. Williams, P.J. Cribb, M.B. Cooke, and A. Hayes The effect of ephedra and caffeine on maximal strength and power in resistance-trained athletes J Strength Cond Res 22 2008 464 470
246. R. DeMeersman, D. Getty, and D.C. Schaefer Sympathomimetics and exercise enhancement: all in the mind? Pharmacol Biochem Behav 28 1987 361 365
247. M.E. Powers Ephedra and its application to sport performance: another concern for the athletic trainer? J Athl Train 36 2001 420 424
248. S. Sang, J.D. Lambert, and C.S. Yang The chemistry and biotransformation of tea constituents Pharmacol Res 64 2011 87 99
249. O.J. Phung, W.L. Baker, and L.J. Matthews Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis Am J Clin Nutr 91 2010 73 81
250. R. Hursel, W. Viechtbauer, and M.S. Westerterp-Plantenga The effects of green tea on weight loss and weight maintenance: a meta-analysis Int J Obes 33 2009 956 961
251. Jurgens TM, Whelan AM, Killian L, et al. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev. http://dx.doi.org/10.1002/14651858.CD008650.pub2.
252. C.M. Colker, D.S. Kalman, and G.C. Torina Effects of Citrus aurantium extract, caffeine, and St. John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults Curr Ther Res 60 1999 145 153
253. J.L. Zenk, S.A. Leikam, L.J. Kassen, and M.A. Kuskowski Effect of Lean System 7 on metabolic rate and composition Nutrition 21 2005 179 185
254. T.E. Graham Caffeine and exercise: metabolism, endurance and performance Sports Med 31 2001 785 807
255. L.M. Burke Caffeine and sports performance Appl Physiol Nutr Metab 33 2008 1319 1334
256. J.K. Davis, and J.M. Green Caffeine and anaerobic performance: ergogenic value and mechanisms of action Sports Med 39 2009 813 832
257. T.A. Astorino, and D.W. Roberson Efficacy of acute caffeine ingestion for short-term high-intensity exercise performance: a systematic review J Strength Cond Res 24 2010 257 265
258. D. Bishop Dietary supplements and team-sport performance Sports Med 40 2010 995 1017
259. J.E. James, R.J. Bloomer, and G. Cox Caffeine and physical performance J Caffeine Res 1 2011 145 151
260. M.H. Malek, T.J. Housh, and J.W. Coburn Effects of eight weeks of caffeine supplementation and endurance training on aerobic fitness and body composition J Strength Cond 20 2006 751 755
261. T.W. Beck, T.J. Housh, and M.H. Malek The acute effects of a caffeine-containing supplement on bench press strength and the time to running exhaustion J Strength Cond 22 2008 1654 1658
262. A.A. Walter, T.J. Herda, and E.D. Ryan Acute effects of a thermogenic nutritional supplement on cycling time to exhaustion and muscular strength in college-aged men J Int Soc Sports Nutr 6 2009 15 10.1186/1550-2783-6-15
263. T.W. Beck, T.J. Housh, and R.J. Schmidt The acute effects of a caffeine-containing supplement on strength, muscular endurance, and anaerobic capabilities J Strength Cond Res 20 2006 506 510
264. P. Eichenberger, S. Mettler, M. Arnold, and P.C. Colombani No effects of three-week consumption of a green tea extract on time trial performance in endurance-trained men Int J Vitam Nutr Res 80 2010 54 64
265. M. Armstrong Atrial fibrillation with rapid ventricular response following use of a dietary supplement containing 1,3 dimethylamylamine and caffeine J Spec Oper Med 12 2012 1 4
266. T.B. Smith, B.A. Staub, and G.M. Natarajan Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium Tex Heart Inst J 41 2014 70 72
267. M.B. Forrester Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers Hum Exp Toxicol 32 2013 18 23
268. R.J. Bloomer, I.C. Harvey, and T.M. Farney Effects of 1,3-dimethylamylamine and caffeine alone or in combination on heart rate and blood pressure in healthy man and women Phys Sports Med 39 2011 111 120
269. R.J. Bloomer, C.G. McCarthy, T.M. Farney, and I.C. Harvey Effect of caffeine and 1,3-dimethylamylamine on exercise performance and blood markers of lipolysis and oxidative stress in trained men and women J Caffeine Res 1 2011 169 177
270. DMAA in dietary supplements. (July 16,2013) Food and Drug Administration website. http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/ucm346576.htm accessed 5/30/2014
271. B. Venhuis, P. Keizers, A. van Riel, and D. de Kaste A cocktail of synthetic stimulants found in dietary supplement associated with serious adverse events Drug Test Anal 2014 10.1002/dta.1664
272. B. Campbell, C. Wilborn, and P. La Bounty International Society of Sports Nutrition position stand: energy drinks J Int Soc Sports Nutr 10 2013 1 http://www.jissn.com/content/10/1/1
273. H.J. Smit, J.R. Cotton, S.C. Hughes, and P.J. Rogers Mood and cognitive performance effects of "energy" drink constituents: caffeine, glucose and carbonation Nutr Neurosci 7 2004 127 139
274. A.B. Scholey, and D.O. Kennedy Cognitive and physiological effects of an "energy drink": an evaluation of the whole drink and of glucose, caffeine and herbal flavoring fractions Psychopharmacology 176 2004 320 330
275. G.E. Giles, C.R. Mahoney, and T.T. Brunyé Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose Pharmacol Biochem Behav 102 2012 569 577
276. C.A. Marczinski, A.L. Stamates, and J. Ossege Subjective state, blood pressure, and behavioral control changes produced by an "energy shot." J Caffeine Res 4 2014 57 63
277. G. Rose Strategy of prevention: lessons from cardiovascular disease Br Med J 282 1981 1847 1849